Title : Clinical Significance of PLA2G2A Expression in Gastric Cancer Patients who Receive Gastrectomy and Adjuvant S-1 - Hatori_2021_Anticancer.Res_41_3583 |
Author(s) : Hatori S , Sakamaki K , Yokohori T , Kimura Y , Hiroshima Y , Hashimoto I , Komori K , Watanabe H , Kano K , Fujikawa H , Aoyama T , Numata M , Yamada T , Tamagawa H , Yamamoto N , Ogata T , Shizawa M , Yukawa N , Morinaga S , Rino Y , Masuda M , Saeki H , Miyagi Y , Oshima T |
Ref : Anticancer Research , 41 :3583 , 2021 |
Abstract : Hatori_2021_Anticancer.Res_41_3583 |
ESTHER : Hatori_2021_Anticancer.Res_41_3583 |
PubMedSearch : Hatori_2021_Anticancer.Res_41_3583 |
PubMedID: 34230154 |
Hatori S, Sakamaki K, Yokohori T, Kimura Y, Hiroshima Y, Hashimoto I, Komori K, Watanabe H, Kano K, Fujikawa H, Aoyama T, Numata M, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Shizawa M, Yukawa N, Morinaga S, Rino Y, Masuda M, Saeki H, Miyagi Y, Oshima T (2021)
Clinical Significance of PLA2G2A Expression in Gastric Cancer Patients who Receive Gastrectomy and Adjuvant S-1
Anticancer Research
41 :3583
Hatori S, Sakamaki K, Yokohori T, Kimura Y, Hiroshima Y, Hashimoto I, Komori K, Watanabe H, Kano K, Fujikawa H, Aoyama T, Numata M, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Shizawa M, Yukawa N, Morinaga S, Rino Y, Masuda M, Saeki H, Miyagi Y, Oshima T (2021)
Anticancer Research
41 :3583